Loading
PDBj
✖
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9Z7M

Human CD38 bound to ligand-ADPR adduct

This is a non-PDB format compatible entry.
Summary for 9Z7M
Entry DOI10.2210/pdb9z7m/pdb
DescriptorADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[4-[2-azanyl-6-[4-[cyclopropyl(methyl)carbamoyl]phenyl]imidazo[1,2-b]pyridazin-3-yl]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate, SULFATE ION, ... (5 entities in total)
Functional Keywordsinhibitor, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight31787.43
Authors
Jain, R.,Nocek, B.P.,Bigelow, L. (deposition date: 2025-11-17, release date: 2026-11-18)
Primary citationShiroodi, R.,Montavon, T.J.,Nelson, B.M.,Randolph, J.T.,O'Flynn, D.E.,Iu, L.,Hutchins, C.W.,Baikstis, T.,Izquierdo-Ferrer, J.,Smyth, D.,Krishnan, N.,Maneshi, M.M.,Brown, J.W.,Afanador, G.A.,Jain, R.,Karunan Partha, S.,Bigelow, L.,Nocek, B.,Talaga, L.,Gopalakrishnan, S.M.,Balakrishnan, A.,Sheehan, M.M.,Kurschner, V.A.,Jejurkar, P.C.,Nacham, O.,Hu, D.,Yarilina, A.,Bradley, N.P.,Chapman, A.M.,Thakur, A.,Panchal, S.C.,Sunose, M.,Zoi, I.,Dart, M.J.,Shotwell, J.B.,Benekareddy, M.,Sadowski, R.N.,Swensen, A.M.
Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors.
J.Med.Chem., 69:13188-13206, 2026
Cited by
PubMed Abstract: Herein, we report the discovery and optimization of a series of cluster of differentiation 38 (CD38) inhibitors derived from a virtual ligand screening (VLS) campaign. VLS identified imidazopyridazine hit , which was optimized to a novel and potent CD38 inhibitor peripheral tool () with an excellent pharmacokinetic profile. A cocrystal structure in addition to biophysical and biochemical characterization of is consistent with uncompetitive inhibition of CD38 via the formation of covalent adduct . Further structure- and property-based modifications of afforded sulfuryl pyrazole () with improved CNS distribution properties. Brain-penetrant thienopyrimidine shows robust rodent pharmacokinetics and target engagement across skin, lung, liver, and brain, making it an excellent CD38 tool for the study of indications requiring engagement of CD38 in the brain.
PubMed: 42178680
DOI: 10.1021/acs.jmedchem.6c00171
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.84 Å)
Structure validation

263157

PDB entries from 2026-11-18

PDB statisticsPDBj update infoContact PDBjnumon